Kollef M H, Sherman G, Ward S, Fraser V J
Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Chest. 1999 Feb;115(2):462-74. doi: 10.1378/chest.115.2.462.
To evaluate the relationship between inadequate antimicrobial treatment of infections (both community-acquired and nosocomial infections) and hospital mortality for patients requiring ICU admission.
Prospective cohort study.
Barnes-Jewish Hospital, a university-affiliated urban teaching hospital.
Two thousand consecutive patients requiring admission to the medical or surgical ICU.
Prospective patient surveillance and data collection.
One hundred sixty-nine (8.5%) infected patients received inadequate antimicrobial treatment of their infections. This represented 25.8% of the 655 patients assessed to have either community-acquired or nosocomial infections. The occurrence of inadequate antimicrobial treatment of infection was most common among patients with nosocomial infections, which developed after treatment of a community-acquired infection (45.2%), followed by patients with nosocomial infections alone (34.3%) and patients with community-acquired infections alone (17.1%) (p < 0.001). Multiple logistic regression analysis, using only the cohort of infected patients (n = 655), demonstrated that the prior administration of antibiotics (adjusted odds ratio [OR], 3.39; 95% confidence interval [CI], 2.88 to 4.23; p < 0.001), presence of a bloodstream infection (adjusted OR, 1.88; 95% CI, 1.52 to 2.32; p = 0.003), increasing acute physiology and chronic health evaluation (APACHE) II scores (adjusted OR, 1.04; 95% CI, 1.03 to 1.05; p = 0.002), and decreasing patient age (adjusted OR, 1.01; 95% CI, 1.01 to 1.02; p = 0.012) were independently associated with the administration of inadequate antimicrobial treatment. The hospital mortality rate of infected patients receiving inadequate antimicrobial treatment (52.1%) was statistically greater than the hospital mortality rate of the remaining patients in the cohort (n = 1,831) without this risk factor (12.2%) (relative risk [RR], 4.26; 95% CI, 3.52 to 5.15; p < 0.001). Similarly, the infection-related mortality rate for infected patients receiving inadequate antimicrobial treatment (42.0%) was significantly greater than the infection-related mortality rate of infected patients receiving adequate antimicrobial treatment (17.7%) (RR, 2.37; 95% CI, 1.83 to 3.08; p < 0.001). Using a logistic regression model, inadequate antimicrobial treatment of infection was found to be the most important independent determinant of hospital mortality for the entire patient cohort (adjusted OR, 4.27; 95% CI, 3.35 to 5.44; p < 0.001). The other identified independent determinants of hospital mortality included the number of acquired organ system derangements, use of vasopressor agents, the presence of an underlying malignancy, increasing APACHE II scores, increasing age, and having a nonsurgical diagnosis at the time of ICU admission.
Inadequate treatment of infections among patients requiring ICU admission appears to be an important determinant of hospital mortality. These data suggest that clinical efforts aimed at reducing the occurrence of inadequate antimicrobial treatment could improve the outcomes of critically ill patients. Additionally, prior antimicrobial therapy should be recognized as an important risk factor for the administration of inadequate antimicrobial treatment among ICU patients with clinically suspected infections.
评估感染(包括社区获得性感染和医院感染)抗菌治疗不足与入住重症监护病房(ICU)患者的医院死亡率之间的关系。
前瞻性队列研究。
巴恩斯-犹太医院,一家大学附属的城市教学医院。
连续2000例需要入住内科或外科ICU的患者。
前瞻性患者监测和数据收集。
169例(8.5%)感染患者的感染抗菌治疗不足。这占655例被评估为患有社区获得性或医院感染患者的25.8%。感染抗菌治疗不足的情况在医院感染患者中最为常见,这些患者在社区获得性感染治疗后发生(45.2%),其次是仅患有医院感染的患者(34.3%)和仅患有社区获得性感染的患者(17.1%)(p<0.001)。仅对感染患者队列(n = 655)进行的多因素logistic回归分析表明,先前使用抗生素(调整后的优势比[OR],3.39;95%置信区间[CI],2.88至4.23;p<0.001)、存在血流感染(调整后的OR,1.88;95%CI,1.52至2.32;p = 0.003)、急性生理与慢性健康状况评估(APACHE)II评分增加(调整后的OR,1.04;95%CI,1.03至1.05;p = 0.002)以及患者年龄降低(调整后的OR,1.01;95%CI,1.01至1.02;p = 0.012)与抗菌治疗不足独立相关。接受抗菌治疗不足的感染患者的医院死亡率(52.1%)在统计学上高于队列中其余无此风险因素的患者(n = 1831)的医院死亡率(12.2%)(相对风险[RR],4.26;95%CI,3.52至5.15;p<0.001)。同样,接受抗菌治疗不足的感染患者的感染相关死亡率(42.0%)显著高于接受充分抗菌治疗的感染患者的感染相关死亡率(17.7%)(RR,2.37;95%CI,1.83至3.08;p<0.001)。使用logistic回归模型发现,感染抗菌治疗不足是整个患者队列医院死亡率的最重要独立决定因素(调整后的OR,4.27;95%CI,3.35至5.44;p<0.001)。其他已确定的医院死亡率独立决定因素包括获得性器官系统紊乱的数量、血管升压药的使用、潜在恶性肿瘤的存在、APACHE II评分增加以及年龄增加,以及在入住ICU时为非手术诊断。
入住ICU患者的感染治疗不足似乎是医院死亡率的重要决定因素。这些数据表明,旨在减少抗菌治疗不足发生的临床努力可能会改善重症患者的结局。此外,先前的抗菌治疗应被视为临床怀疑感染的ICU患者抗菌治疗不足的重要风险因素。